Cargando…
Effects of Telbivudine Treatment on the Circulating CD4(+) T-Cell Subpopulations in Chronic Hepatitis B Patients
CD4(+) T cells serve as master regulators of the adaptive immune response to HBV. However, CD4(+) T-cell subsets are heterogeneous, and it remains unknown how the antiviral agents affect the different CD4(+) T cell subtypes. To this end, the expressions of signature transcription factors and cytokin...
Autores principales: | Zheng, Yanhua, Huang, Zemin, Chen, Xianhua, Tian, Yi, Tang, Jun, Zhang, Yi, Zhang, Xiaomin, Zhou, Jijun, Mao, Qing, Ni, Bing, Wang, Qinghong, Wu, Yuzhang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337496/ https://www.ncbi.nlm.nih.gov/pubmed/22570512 http://dx.doi.org/10.1155/2012/789859 |
Ejemplares similares
-
Activated IL-23/IL-17 pathway closely correlates with increased Foxp3 expression in livers of chronic hepatitis B patients
por: Wang, Qinghong, et al.
Publicado: (2011) -
Hepatitis B Virus Induces IL-23 Production in Antigen Presenting Cells and Causes Liver Damage via the IL-23/IL-17 Axis
por: Wang, Qinghong, et al.
Publicado: (2013) -
Safety and efficacy of telbivudine for the treatment of chronic hepatitis B
por: Osborn, Melissa K
Publicado: (2009) -
Telbivudine can safely reduce mother-to-child transmission in chronic hepatitis B women after 12 weeks of gestation
por: Han, Li-fen, et al.
Publicado: (2019) -
Infant immune response to hepatitis B vaccine after fetal exposure to telbivudine
por: Li, Yandi, et al.
Publicado: (2022)